BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  BD to Present at Bank of America Securities 2023 Health Care Conference

  BD, a leading global medical technology company, announced that it will present at the Bank of America Securities 2023 Health Care Conference on Tuesday, May 9, 2023 at 11:00 am Eastern Time.

  April 26, 2023

   · 

  1 min read
• Business

  Jazz Pharmaceuticals to Report 2023 First Quarter Financial Results on May 10, 2023

  Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2023 first quarter financial results on Wednesday, May 10, 2023, after the close of the U.S. financial markets.

  April 26, 2023

   · 

  1 min read
• Business

  Bruker Announces Date and Time of First Quarter 2023 Earnings Release and Webcast

  Bruker Corporation announced it will report first quarter 2023 financial results before market opening on Thursday, May 4, 2023.

  April 26, 2023

   · 

  2 min read
• Business

  CONMED Corporation Announces First Quarter 2023 Financial Results

  CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2023.

  April 26, 2023

   · 

  11 min read
• Business

  Bristol Myers Squibb Announces Leadership Transition Plan - April 26, 2023

  Bristol Myers Squibb announced that Giovanni Caforio, MD, Chairman of the Board and Chief Executive Officer, has decided to retire as Chief Executive Officer, effective November 1, 2023.

  April 26, 2023

   · 

  5 min read
• Biotech Bay

  Silk Road Medical to Present at the BofA Securities 2023 Healthcare Conference

  Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will participate in the upcoming BofA Securities 2023 Healthcare Conference.

  April 26, 2023

   · 

  1 min read
• Business

  Dyadic to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023

  Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI) today announced that it will report its financial results for first quarter 2023 and host a corporate update conference call on Wednesday, May 10, 2023.

  April 26, 2023

   · 

  3 min read
• Drug Development

  Biofrontera Inc. Announces Last Patient Out in Phase I Study to Evaluate Safety and Tolerability in Treating Actinic Keratosis Using 3 Tubes of Ameluz(R)

  Biofrontera Inc. today announced that that the last patient in a Phase I study to evaluate the safety and tolerability of Ameluz.

  April 26, 2023

   · 

  4 min read
• Drug Development

  Novocure Announces Presentation of Results of the LUNAR Phase 3 Clinical Trial in Non-Small Cell Lung Cancer at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

  Novocure (NASDAQ: NVCR) today announced the results of the LUNAR phase 3 clinical trial in metastatic, non-small cell lung cancer (NSCLC) will be presented for the first time at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, to be held from June 2 to June 6.

  April 26, 2023

   · 

  7 min read
• Drug Development

  Allogene Therapeutics Announces Presentation of Phase 1 Data from the ALLO-501/501A Trials in Large B Cell Lymphoma at the American Society of Clinical Oncology (ASCO) Annual Meeting

  Allogene Therapeutics, Inc. today announced it will present updated data from the Phase 1 ALPHA/ALPHA2 trials of ALLO-501/501A at the American Society of Clinical Oncology (ASCO) Annual Meeting June 2 – 6, 2023 in Chicago, Illinois.

  April 26, 2023

   · 

  5 min read